Vivian Mumbiro
Harare, HA, Zimbabwe
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment.
Journal: The Journal of antimicrobial chemotherapy
Published: February 19, 2026
Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.
Journal: EClinicalMedicine
Published: January 08, 2026
Pharmacokinetic data of atazanavir/ritonavir in second-line treatment of children living with HIV.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 16, 2025
Second-Line Antiretroviral Therapy for Children Living with HIV in Africa.
Journal: The New England journal of medicine
Published: May 14, 2025
Pharmacokinetics of lopinavir/ritonavir in second-line treatment of children with HIV in the CHAPAS-4 trial.
Journal: AIDS (London, England)
Published: April 18, 2025
Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 21, 2023
First-Line Antituberculosis Drug Concentrations in Infants With HIV and a History of Recent Admission With Severe Pneumonia.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: July 11, 2023
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 15, 2023
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial.
Journal: The Lancet. Child & adolescent health
Published: March 06, 2023
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: January 17, 2023
Brief Report: Suboptimal Lopinavir Exposure in Infants on Rifampicin Treatment Receiving Double-dosed or Semisuperboosted Lopinavir/Ritonavir: Time for a Change.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: November 10, 2022
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial.
Journal: The lancet. HIV
Published: March 28, 2022
Last Updated: 09/26/2026